Jump to main content
Jump to site search
PLANNED MAINTENANCE Close the message box

There will be scheduled maintenance work beginning on Saturday 15th June 2019 at 8:30 am through to Sunday 16th June 2019 at 11:30 pm (BST).

During this time our website may be temporarily affected. We apologise for any inconvenience this might cause and thank you for your patience.


Issue 1, 2004
Previous Article Next Article

Dendrimers in drug research

Author affiliations

Abstract

Dendrimers are versatile, derivatisable, well-defined, compartmentalised chemical polymers with sizes and physicochemical properties resembling those of biomolecules e.g. proteins. The present critical review (citing 158 references) briefly describes dendrimer design, nomenclature and divergent/convergent dendrimer synthesis. The characteristic physicochemical features of dendrimers are highlighted, showing the effect of solvent pH and polarity on their spatial structure. The use of dendrimers in biological systems are reviewed, with emphasis on the biocompatibility of dendrimers, such as in vitro and in vivo cytotoxicity, as well as biopermeability, biostability and immunogenicity. The review deals with numerous applications of dendrimers as tools for efficient multivalent presentation of biological ligands in biospecific recognition, inhibition and targeting.

Dendrimers may be used as drugs for antibacterial and antiviral treatment and have found use as antitumor agents. The review highlights the use of dendrimers as drug or gene delivery devices in e.g. anticancer therapy, and the design of different host–guest binding motifs directed towards medical applications is described.

Other specific examples are the use of dendrimers as ‘glycocarriers’ for the controlled multimeric presentation of biologically relevant carbohydrate moieties which are useful for targeting modified tissue in malignant diseases for diagnostic and therapeutic purposes. Finally, the use of specific types of dendrimers as scaffolds for presenting vaccine antigens, especially peptides, for use in vaccines is presented.

Graphical abstract: Dendrimers in drug research

Back to tab navigation

Publication details

The article was received on 20 Aug 2003 and first published on 05 Dec 2003


Article type: Critical Review
DOI: 10.1039/B309043B
Chem. Soc. Rev., 2004,33, 43-63

  •   Request permissions

    Dendrimers in drug research

    U. Boas and P. M. H. Heegaard, Chem. Soc. Rev., 2004, 33, 43
    DOI: 10.1039/B309043B

Search articles by author

Spotlight

Advertisements